AXYNC, created in 2003 (Netherlands), from 402 sister brands and 17477 competing brands. The AXYNC brand is owned by Merck & Co, a company listed in New York. AXYNC is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Merck & Co
(AXYNC)
over 5 years*
USD 219.39